In line with several studies that have investigated the expression levels of SPP1 and OPN in different types of cancer in people65,67,68, these findings might support the use of SPP1 or OPN expression as prognostic biomarkers in CAA and COSCC. The gene discussed is SPP1; the disease is cancer.